Enterococcus Species, Streptococcus gallolyticus Group, and Leuconostoc Species

William R. Miller, Cesar A. Arias, Barbara E. Murray

Research output: Chapter in Book/Report/Conference proceedingChapter

5 Scopus citations

Abstract

Enterococci are a leading cause of health care-associated infections and often present a therapeutic challenge to physicians due to both intrinsic and acquired resistance to antibiotics. The Streptococcus gallolyticus group of organisms are a notable cause of bacteremia and endocarditis, especially in patients with gastrointestinal malignancy. Leuconostoc spp. colonize the gastrointestinal tract of humans and sporadically cause disease, typically in immunosuppressed individuals. This chapter reviews the microbiology, epidemiology, clinical presentations, and approach to therapy of infections caused by enterococci, members of the Streptococcus gallolyticus group, and Leuconostoc spp.

Original languageEnglish (US)
Title of host publicationMandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition
Subtitle of host publicationVolume 1-2
PublisherElsevier
Pages2492-2504.e4
Volume2
ISBN (Electronic)9780323482554
ISBN (Print)9780323775564
DOIs
StatePublished - Jan 1 2019

Keywords

  • Enterococcus
  • Enterococcus faecalis
  • Enterococcus faecium
  • VRE
  • antimicrobial resistance
  • colonization of the gastrointestinal tract
  • daptomycin
  • daptomycin resistance
  • endocarditis
  • gram-positive
  • linezolid
  • meningitis
  • nosocomial infections
  • oritavancin
  • tigecycline
  • urinary tract infections
  • vancomycin resistance

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Enterococcus Species, Streptococcus gallolyticus Group, and Leuconostoc Species'. Together they form a unique fingerprint.

Cite this